217 related articles for article (PubMed ID: 25082586)
1. Induced pluripotent stem cells for the study of cardiovascular disease.
Savla JJ; Nelson BC; Perry CN; Adler ED
J Am Coll Cardiol; 2014 Aug; 64(5):512-9. PubMed ID: 25082586
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders.
Josowitz R; Carvajal-Vergara X; Lemischka IR; Gelb BD
Curr Opin Cardiol; 2011 May; 26(3):223-9. PubMed ID: 21451408
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro.
Malan D; Friedrichs S; Fleischmann BK; Sasse P
Circ Res; 2011 Sep; 109(8):841-7. PubMed ID: 21799153
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
[TBL] [Abstract][Full Text] [Related]
5. Modeling long QT syndromes using induced pluripotent stem cells: current progress and future challenges.
Friedrichs S; Malan D; Sasse P
Trends Cardiovasc Med; 2013 May; 23(4):91-8. PubMed ID: 23266156
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
Tanaka A; Yuasa S; Node K; Fukuda K
Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
[TBL] [Abstract][Full Text] [Related]
7. Making cardiomyocytes: how mechanical stimulation can influence differentiation of pluripotent stem cells.
Geuss LR; Suggs LJ
Biotechnol Prog; 2013; 29(5):1089-96. PubMed ID: 23956196
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.
Davis RP; Casini S; van den Berg CW; Hoekstra M; Remme CA; Dambrot C; Salvatori D; Oostwaard DW; Wilde AA; Bezzina CR; Verkerk AO; Freund C; Mummery CL
Circulation; 2012 Jun; 125(25):3079-91. PubMed ID: 22647976
[TBL] [Abstract][Full Text] [Related]
9. Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes.
Xu XQ; Sun W
J Cell Biochem; 2013 Jan; 114(1):39-46. PubMed ID: 22903726
[TBL] [Abstract][Full Text] [Related]
10. Recent progress of iPSC technology in cardiac diseases.
Funakoshi S; Yoshida Y
Arch Toxicol; 2021 Dec; 95(12):3633-3650. PubMed ID: 34657219
[TBL] [Abstract][Full Text] [Related]
11. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
12. Pluripotent stem cell derived cardiovascular progenitors--a developmental perspective.
Birket MJ; Mummery CL
Dev Biol; 2015 Apr; 400(2):169-79. PubMed ID: 25624264
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
Iglesias-García O; Pelacho B; Prósper F
J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cell technology and inherited arrhythmia syndromes.
Ross SB; Fraser ST; Semsarian C
Heart Rhythm; 2018 Jan; 15(1):137-144. PubMed ID: 28823602
[TBL] [Abstract][Full Text] [Related]
15. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart.
Sequiera GL; Mehta A; Ooi TH; Shim W
Life Sci; 2013 Jan; 92(1):63-71. PubMed ID: 23142239
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells in cardiovascular research.
Sinnecker D; Dirschinger RJ; Goedel A; Moretti A; Lipp P; Laugwitz KL
Rev Physiol Biochem Pharmacol; 2012; 163():1-26. PubMed ID: 22447279
[TBL] [Abstract][Full Text] [Related]
17. Get with the (re)program: cardiovascular potential of skin-derived induced pluripotent stem cells.
Tulloch NL; Pabon L; Murry CE
Circulation; 2008 Jul; 118(5):472-5. PubMed ID: 18663099
[No Abstract] [Full Text] [Related]
18. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
Murata M; Tohyama S; Fukuda K
Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
[TBL] [Abstract][Full Text] [Related]
19. Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects.
Samak M; Hinkel R
Cells; 2019 Nov; 8(12):. PubMed ID: 31783680
[TBL] [Abstract][Full Text] [Related]
20. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
